Yes, Skyrizi (risankizumab) is a specialty drug. It is classified this way by insurers, distributed almost exclusively through specialty pharmacies, and requires prior authorization before most health plans will cover it. If you’ve been prescribed Skyrizi or are exploring treatment options, understanding what “specialty drug” means in practice will help you navigate the cost, pharmacy logistics, and insurance hurdles involved.
What Makes Skyrizi a Specialty Drug
The “specialty drug” label isn’t just about price, though price is a big part of it. A medication earns this classification when it checks several boxes: high cost, complex handling or storage requirements, the need for clinical monitoring, and limited distribution. Skyrizi hits all of them.
Skyrizi is a biologic, meaning it’s made from living cells rather than synthesized chemically like a standard pill. It works by blocking a specific immune signaling protein called interleukin-23, which drives inflammation in conditions like psoriasis and Crohn’s disease. Because it’s a large, fragile protein molecule, it must be refrigerated between 36°F and 46°F, kept in its original carton to protect it from light, and never frozen or shaken. These storage demands alone prevent it from sitting on a typical pharmacy shelf.
The cost also places it firmly in specialty territory. A single 150 mg pen injector carries a wholesale price of roughly $7,000 per dose. Depending on the condition being treated and the dosing schedule, annual costs can climb well into five figures before insurance.
How You Actually Get It
You won’t pick up Skyrizi at your local pharmacy counter. It’s dispensed through a network of designated specialty pharmacies equipped to store and ship temperature-sensitive biologics. Major specialty pharmacies that carry Skyrizi include CVS Specialty, Walgreens Specialty Pharmacy, Accredo, Optum Specialty Pharmacy, CenterWell Specialty Pharmacy, and about a dozen others. These pharmacies also provide patient education, helping you learn proper injection technique or coordinating infusion appointments.
The way you receive Skyrizi depends on your condition. For plaque psoriasis and psoriatic arthritis, it’s a 150 mg subcutaneous injection you can give yourself at home after training. For Crohn’s disease and ulcerative colitis, treatment starts with intravenous infusions (600 mg for Crohn’s, 1,200 mg for ulcerative colitis) administered by a healthcare provider, then transitions to self-injected maintenance doses of 180 mg or 360 mg. The infusion phase adds another layer of complexity that reinforces its specialty classification.
What Skyrizi Treats
Skyrizi is FDA-approved for four conditions: moderate-to-severe plaque psoriasis in adults, active psoriatic arthritis, moderately to severely active Crohn’s disease, and moderately to severely active ulcerative colitis. In all four cases, it’s generally reserved for people whose disease hasn’t responded well to simpler, less expensive treatments.
The Prior Authorization Process
Because Skyrizi is a high-cost specialty biologic, virtually every insurance plan requires prior authorization before covering it. This means your doctor submits documentation proving you meet specific criteria, and your insurer reviews it before approving the prescription. The process can take days to weeks.
The exact requirements vary by insurer and condition, but they follow a common pattern. For plaque psoriasis, insurers typically want to see that the disease affects more than 10% of your body surface area (or involves sensitive areas like the face, hands, or genitals) and that you’ve already tried and failed other treatments. These usually include phototherapy or older systemic medications like methotrexate, and often at least two other biologic drugs as well. For psoriatic arthritis, plans commonly require documented failure of at least two disease-modifying drugs including methotrexate, plus trials of other biologics.
For Crohn’s disease and ulcerative colitis, insurers verify that you’re following the approved treatment sequence, starting with the intravenous induction phase before moving to maintenance injections. Tuberculosis screening within the past year is a standard requirement across all conditions, since blocking immune signaling proteins can reactivate latent TB infections.
Renewal isn’t automatic either. When it’s time to reauthorize, your insurer will look for evidence that Skyrizi is actually working, such as reduced symptoms, slowed disease progression, or improved physical function.
What You’ll Actually Pay
Your out-of-pocket cost depends heavily on your insurance plan. Specialty drugs often fall into the highest copay tier, meaning you could face coinsurance of 25% to 50% of the drug’s cost rather than a flat copay. Without assistance, that can mean thousands of dollars per dose.
AbbVie, the company that makes Skyrizi, offers a savings program called Skyrizi Complete that can significantly reduce your cost. If you have commercial insurance, you may pay as little as $0 per dose, with a maximum annual benefit of $14,000 in copay assistance. The program is not available if you’re covered by any government-funded insurance, including Medicare, Medicaid, TRICARE, or Veterans Affairs programs. If you’re on Medicare or Medicaid, you’ll need to work with your plan directly or look into patient assistance foundations that help cover specialty drug costs.
Why This Classification Matters for You
The specialty drug label affects your experience at almost every step. You’ll go through a longer approval process before starting treatment. Your medication will arrive by mail from a specialty pharmacy rather than being ready for pickup down the street. You may need to coordinate delivery around your schedule to make sure someone is home to receive a refrigerated package. And the financial side requires more active management, whether that means enrolling in a savings program, appealing a denial, or tracking your annual out-of-pocket spending against your plan’s maximums.
On the positive side, specialty pharmacies often assign you a dedicated coordinator who handles refills, tracks your dosing schedule, and helps troubleshoot insurance issues. Many patients find this level of support helpful, especially during the first few months of treatment when prior authorizations, injection training, and shipping logistics all overlap.